Access cutting-edge heart failure treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access heart failure specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure treatment provided free
Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients with heart failure and reduced ejection fraction (HFrEF) who are intolerant or ineligible to receive treatment with steroidal mineralocorticoid receptor antagonists (sMRA).
Sponsor: Colorado Prevention Center
Check if you qualify for this heart failure clinical trial in Kansas City, MO
If you're searching for heart failure treatment options in Kansas City, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.